Sign in Subscribe
Drug resistance

Advances in Epilepsy Treatment: A Review of Pharmacological and Non-Invasive Brain Stimulation Approaches

Strategic Insights

— 2 min read

Research has shown that epilepsy is a prevalent neurological disorder affecting more than 50 million individuals worldwide, characterized by seizures and often associated with complications such as cognitive impairments and an increased risk of sudden unexpected death in epilepsy (SUDEP). Despite advancements in pharmacological treatments, one-third of patients develop drug resistance and experience serious side effects related to drug therapy, highlighting the need for alternative therapeutic approaches. Non-invasive brain stimulation (NIBS) techniques, such as transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), and transcranial ultrasound stimulation (TUS), have emerged as promising alternatives, with the potential to modulate brain activity and reduce side effects.

Key Takeaways:

  • The study, conducted by researchers from Shahid Beheshti University, highlights the urgent need for alternative therapeutic approaches in managing epilepsy, particularly for patients who develop drug resistance.
  • Non-invasive brain stimulation (NIBS) techniques, such as TMS, tDCS, and TUS, have shown potential in treating drug-resistant epilepsy, with fewer side effects compared to pharmacological treatments.
  • The study explores the efficacy, mechanisms, and side effects of pharmacological treatments and selected NIBS techniques, emphasizing their roles in managing epilepsy.
  • The researchers aim to provide insights into optimizing epilepsy treatment strategies and improving patient outcomes through a comparison of pharmacological and NIBS approaches.
  • The study suggests that NIBS alone or in combination with pharmacological therapy is a promising method for patients with epilepsy, with future research focusing on effective protocols and mechanisms.
  • The researchers highlight the need for further investigation into the variability in stimulation protocols and patient responsiveness in NIBS techniques.
  • The study emphasizes the importance of exploring alternative therapeutic approaches to improve patient outcomes and quality of life for individuals with epilepsy.

Statistics:

  • Over 50 million individuals worldwide are affected by epilepsy.
  • One-third of patients develop drug resistance to pharmacological treatments.
  • Serious side effects related to drug therapy are a significant concern in epilepsy management.
  • NIBS techniques, such as TMS, tDCS, and TUS, have shown potential in modulating brain activity and reducing side effects.
  • The study concludes that NIBS alone or in combination with pharmacological therapy is a promising method for patients with epilepsy.
  • The researchers aim to optimize epilepsy treatment strategies and improve patient outcomes through further investigation.

Sources:

  • Dual strategies for epilepsy management employing pharmacological and non-invasive brain stimulation approaches. Frontiers in Neurology, 2025,16.
  • Frontiers in Neurology (http://frontiersin.org/neurology)
  • Frontiers Media S.A. (publisher)
  • https://doi-org.sdpl.idm.oclc.org/10.3389/fneur.2025.1541064 (free version of the journal article)
  • Masoud Afshari, Department of Cognitive Psychology, Institute for Cognitive and Brain Sciences, Shahid Beheshti University, Tehran, Iran (corresponding author)
  • Gila Pirzad Jahromi, Mehrdad Roghani (co-authors)

Read more